ALAMEDA, Calif.– LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at www.genecards.org. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann […]
Ipswich, MA – New England Biolabs, Inc. (NEB) launched their new NEBNext® “Ultra” kits at the recent American Society for Human Genetics (ASHG) annual meeting. These kits provide streamlined, low-input methods to prepare DNA and RNA libraries for Illumina® next generation sequencing. The supplied protocols and reagents are designed to maximize useful data from a […]
CHICAGO, Ill. –– NanoInk’s NanoFabrication Systems Division is pleased to announce that the University of Glasgow’s Biomedical Engineering Research Division (part of the school of engineering) has recently purchased and installed a DPN 5000 System – a dedicated, versatile instrument capable of patterning a variety of materials with nanoscale accuracy and precision. The NanoInk system […]
SAN DIEGO, — Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced release 6.1 of the Accelrys Materials Studio® modeling and simulation environment, providing seamless integration with the Accelrys Pipeline Pilot scientific authoring application, the scientifically aware Accelrys Enterprise Platform and Accelrys Materials Studio Collection. This newly integrated offering […]
Munich, Germany, – Definiens AG, the leader in image analysis for Digital Pathology, today announced that Dr. Gerald Möller, has joined the company’s supervisory board as an independent member and has been appointed chairman. Following the recent financing round, Dr. Möller will guide the expansion of Definiens’ current business and the development and commercialization of […]
LEXINGTON, Mass. –– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that the University College London (UCL) Cancer Institute has adopted its ThunderStorm™ System as a centralized platform for the validation of genomic and epigenomic targets from clinical and non-clinical studies, including follow-ups for genome-wide and epigenome-wide association studies (GWAS and EWAS), as well […]
Marcy l’Etoile (France) and Lexington, MA (U.S.) –— bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux […]
CARLSBAD, Calif., — MO BIO Laboratories, Inc., the leader in soil, stool and microbial nucleic acid purification, announces the launch of the PowerFecal™ DNA Isolation Kit. The kit is optimized for isolation of high quality DNA from stool, gut material and biosolids, and provides high quality DNA for use in characterizing the human microbiome. The […]
MADISON, Wis.–Promega Corporation celebrates the opening of a new facility for its China operations. The new site for Shanghai Promega Biological Products, Ltd. both replaces an existing molecular biology reagent production site and it provides additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market. Since its purchase in June […]
San Jose, CA – line of Flow Cytometry platforms which include the A600 High Throughput Auto Sampler and Stratedigm’s suite of Flow cytometer analyzers, ranging from the entry level two laser, eight parameter SE520 model to Stratedigm’s flagship the S1000Ex, which can be configured with up to four laser and eighteen parameters. The A700 High […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
